Karachi: Highnoon Laboratories Limited has disclosed a recent transaction involving one of its directors, Ms. Tehmina Saeed Chaudhury, as per the regulatory requirements set by the Pakistan Stock Exchange (PSX). This announcement was made in a formal report dated October 19, 2026.

The transaction, executed on October 15, 2026, involved the sale of 10,000 shares by Ms. Chaudhury. The shares were sold at a rate of 916.71 per share, in the Central Depository Company (CDC) form, under the ready market category. The company has assured that this transaction will be reviewed in the upcoming board meeting, where any potential non-compliances will be duly highlighted, as stipulated in clause No. 5.6.1.(d) of the PSX Regulations.

According to information available from the Pakistan Stock Exchange (PSX), such disclosures are mandatory to ensure transparency and maintain investor confidence in the market. The transaction details have been confirmed for presentation at the board meeting, aligning with regulatory compliance requirements.

Highnoon Laboratories Limited remains committed to upholding the standards set forth by the PSX, ensuring that all transactions by its directors, executives, and substantial shareholders are fully disclosed and scrutinized according to established guidelines.